DIA Biosimilars 2013

Technology Solutions

Kendle Updates Biostatistics Platform

Wednesday, March 17, 2010 07:00 AM

Cincinnati-based contract research organization (CRO) Kendle has implemented a new biostatistics infrastructure that the company said will enhance the analysis and delivery of clinical trial data for customers.

More... »

Cenduit: Now with Patient Reminders

ClearTrial Launches Study Forecasting Service

Tuesday, March 16, 2010 06:30 AM

ClearTrial, a provider of clinical trial software, recently launched its Study Costing and Optimization Service (SCOS), a product that combines ClearTrial’s existing trial management software with the consultation services of the company’s clinical services staff. ClearTrial said the new offering will give smaller biopharma companies more control over clinical trial costs, resources and timelines.

More... »

CRF Health – eCOA Forum

INC Research Provides ePRO Services Through Invivodata Partnership

Friday, March 12, 2010 06:34 AM

Raleigh, N.C.-based CRO  INC Research added electronic patient reported outcomes (ePRO) services to its offerings through a partnership with ePRO provider invivodata. Prior to the formation of the strategic partnership, the two companies collaborated on multiple international clinical trials.

More... »

eResearch Technology Revenues Down 60% in ‘09

Wednesday, March 3, 2010 06:05 AM

Philadelphia-based eResearch Technology (ERT) reported a 60% drop in net income in 2009 compared with 2008. Net income in 2009 was $10.7 million, or $0.22 per diluted share, compared with $25 million, or $0.48 per diluted share, for full-year 2008.

More... »

Healogica to Close, Plans to Sell Trial Matchmaking Technology

Monday, March 1, 2010 08:31 AM

Healogica is the latest clinical trial listing service to shut its doors, but the company’s trial matchmaking technology may live on if company founders get their wish.

More... »

Oracle Product Improves Transparency in Multi-site Trials

Friday, February 12, 2010 06:46 AM

Oracle is releasing a new business intelligence system to help sponsors and CROs monitor multi-site clinical trials.

More... »

’09 Acquisitions Bring Phase Forward Revenues Up, Profits Down

Friday, February 5, 2010 10:19 AM

Phase Forward’s fourth quarter revenues jumped 22% but profits went down, the company reported Thursday night. Phase Forward’s share price was down 26.7% to $10.88 in early morning trading.

More... »

Clinilabs Launches New Document Management System

Thursday, February 4, 2010 07:02 AM

New York-based contract research organization (CRO) Clinilabs released its own document management system that the company said will significantly reduce the cost of information management and clinical monitoring and auditing during clinical trials.

More... »

Guest Commentary: SaaS and Pharmacovigilance—A Vital Partnership

Wednesday, December 23, 2009 07:36 AM

Michael Reynolds, APCER Pharma

More... »

i3, Acurian in Patient Recruitment Deal

Tuesday, December 1, 2009 08:01 AM

Pharmaceutical services company i3 has entered into an agreement with Acurian, a provider of patient recruitment and retention solutions, to provide study sponsors with a more robust solution to recruit investigators for clinical trials. 

More... »

CenterWatch
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs